|
Kovarik, J; Bozzotti, P; Love-Homan, L et al. (1999) CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming. J Immunol 162:1611-7
|
|
Weeratna, R; Brazolot Millan, C L; Krieg, A M et al. (1998) Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev 8:351-6
|
|
Yi, A K; Krieg, A M (1998) CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel. J Immunol 160:1240-5
|
|
Davis, H L; Weeratna, R; Waldschmidt, T J et al. (1998) CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol 160:870-6
|
|
Krieg, A M; Love-Homan, L; Yi, A K et al. (1998) CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J Immunol 161:2428-34
|
|
Redford, T W; Yi, A K; Ward, C T et al. (1998) Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides. J Immunol 161:3930-5
|
|
Yi, A K; Chang, M; Peckham, D W et al. (1998) CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol 160:5898-906
|
|
Krieg, A M; Wu, T; Weeratna, R et al. (1998) Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci U S A 95:12631-6
|
|
Moldoveanu, Z; Love-Homan, L; Huang, W Q et al. (1998) CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16:1216-24
|
|
Yi, A K; Tuetken, R; Redford, T et al. (1998) CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. J Immunol 160:4755-61
|
Showing the most recent 10 out of 24 publications
